SCHEMBL31708212

SCHEMBL31708212

CC(=O)Oc1cccc2[nH]cc(C(=O)C(=O)NCCF)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ MTNR1A P48039 1/20 0.43
▸ MTNR1B P49286 1/20 0.43
▸ ALOX5 P09917 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ IGF1R P08069 1/20 0.42
▸ GABRP O00591 3/20 0.41
▸ GABRD O14764 3/20 0.41
▸ GABRA1 P14867 3/20 0.41
▸ GABRB1 P18505 3/20 0.41
▸ GABRG2 P18507 3/20 0.41
▸ GABRB3 P28472 3/20 0.41
▸ GABRA5 P31644 3/20 0.41
▸ GABRA3 P34903 3/20 0.41
▸ GABRA2 P47869 3/20 0.41
▸ GABRB2 P47870 3/20 0.41
▸ GABRA4 P48169 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30276861 0.87 ALOX5 (0.44) MAPTMEN1KMT2AMTNR1AMTNR1B
SCHEMBL31708098 0.85 ALOX5 (0.43) MAPTMEN1KMT2AMTNR1AMTNR1B
SCHEMBL31708107 0.83 ALOX5 (0.41) MAPTMEN1KMT2AMTNR1AMTNR1B
SCHEMBL31708134 0.83 SLC22A6 (0.47) MAPTMEN1KMT2AMTNR1AMTNR1B
SCHEMBL31708138 0.80 SLC22A6 (0.44) MTNR1AMTNR1BALOX5SLC22A6
SCHEMBL30712078 0.79 SLC22A6 (0.50) MTNR1AMTNR1BSLC22A6HDAC3HDAC1
SCHEMBL31708071 0.78 RAB9A (0.52) MAPTMTNR1AMTNR1BNPC1RAB9A
SCHEMBL20898149 0.78 SLC22A6 (0.49) MTNR1AMTNR1BSLC22A6HDAC3HDAC1
SCHEMBL29504147 0.78 SLC22A6 (0.49) MTNR1AMTNR1BSLC22A6HDAC3HDAC1
SCHEMBL25792506 0.77 SLC22A6 (0.58) MAPTMEN1KMT2AMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
Send feedback